Zusammenfassung
Die gesundheitliche Bedeutung der Adipositas ist weniger durch die Adipositas per se als vielmehr durch Folgekrankheiten charakterisiert. Krankheiten können sich zum einen durch die große Körperfettmasse mit erhöhten statischen Belastungen und Verdrängung von Organen einstellen. Zum anderen sezerniert das vermehrte Fettgewebe eine Reihe von Produkten mit hormonellen, entzündlichen und anderen Eigenschaften, was zu metabolischen Komplikationen und Schädigungen an vielen Organen führen kann. Das Risiko für Folgekrankheiten hängt neben einer genetischen Prädisposition von Ausmaß und Dauer der Adipositas sowie von der Fettverteilung ab. Da sich bei nahezu allen adipösen Patienten im Laufe ihres Lebens Folgekrankheiten einstellen, sollten sie gemäß ihren Möglichkeiten informiert werden und die Adipositas als eine chronische Krankheit wahrnehmen. Die einzelnen Folgekrankheiten werden hinsichtlich Epidemiologie, Klinik, Pathophysiologie, Morbidität und Mortalität dargestellt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome. A joint meeting interim statement of the international diabetes federation task force on epidemiology and prevention. Circulation 120:1640–1645
Andersen RE, Crespo CJ, Bartlett SJ, Bathon JM, Fontaine KR (2003) Relationship between body weight gain and significant knee, hip, and back pain in older Americans. Obes Res 11:1159–1162
Ärnlöv J, Ingelsson E, Sundström J et al (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121:230–236
Aune D, Sen A, Norat T et al (2016) Body mass index, abdominal fatness and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation 133:639–649
Banim PJR, Luben RN, Bulluck H et al (2011) The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). Eur J Gastroent Haematol 23:733–740
Bramlage P, Pittrow D, Wittchen HU, Kirch W, Boehler S, Lehnert H, Hoefler M, Unger T, Sharma AM (2004) Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypert 17:904–910
Canoy D, Boekholdt SM, Wareham N et al (2007) Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in Norfolk cohort. A population based prospective study. Circulation 116:2933–2943
Castro-Anon O, Perez de Liano L, De la Fuente Sanchez S et al (2015) Obesity-hypoventilation syndrome: increased risk of death over sleep apnea. PLOS ONE do:https://doi.org/10.137/journal.pone0117808
Chang P, Friedenberg F (2014) Obesity & GERD. Gastroenterol Clin North Am 43:161–173
Fabris de Souza SA, Faintuch J, Valezi AC et al (2013) Postural changes in morbidly obese patients. Obes Surg 15:1013–1016
Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF (1988) Obesity and knee osteoarthritis. The Framingham study. Ann Int Med 109:18–24
Field AE, Coakley EH, Must A et al (2011) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581–1586
Han TS, Schouten JSAG, Lean MEJ, Seidell JC (1997) The prevalence of low back pain and associations with body fatness, fat distribution and height. Int J Obes 21:600–607
Hashimoto Y, Matsudaira K, Sawada SS et al (2017) Obesity and low back pain: a retrospective cohort study of Japanese males. J Phys Ther Sci 29:978–983
Hauner H, Köster I, Schubert I (2007) Trends in der Prävalenz und ambulanten Versorgung von Menschen mit Diabetes mellitus im Zeitraum 1998 bis 2004: eine Analyse der Versichertenstichprobe AOK Hessen/KN Hessen. Dtsch Ärztebl 104:A2799–A2805
Heitman J, Schneider H, Grote L, Peter JH (1993) Schlafapnoe und Adipositas. Adipositas 5:18–22
Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347:305–313
Khalid U, Ather S, Bavishi C et al (2014) Premorbid body-mass index and mortality after incident heart failure: the atherosclerosis risk in communities study. J Am Coll Cardiol 64:2743–2749
Kitade H, Chen G, Ni Y, Ota T (2017) Nonalcoholic fatty liver disease and insulin resistance: new insights and potentional new statements. Nutrients 9:387–399
Kramer CK, Zinman B, Retnakaran R (2013) Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Int Med 159:758–769
Landsberg L, Aronne LJ, Beilin LJ et al (2012) Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment – a position paper of the obesity society and the American society of hypertension. Obesity 21:8–24
Lee SK, Kim SH, Cho G-Y et al (2013) Obesity phenotype and incident hypertension: a prospective community-based cohort study. J Hypertens 31:145–151
Li L, Liu DW, Wang ZY et al (2016) Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Res 17:510–519
Lu Y, Hajifathalian K, Ezzati M et al (2014) Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1,8 million participants. Lancet 15:970–983
McGill HC, McMahan CA, Hederick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group (2002) Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105:2712–2718
Meisinger C, Döring A, Thorand B et al (2006) Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? Am J Clin Nutr 84:483–489
Messier SP (2008) Obesity and osteoarthritis: disease genesis and nonpharmalogical weight management. Rheum Dis Clin North Am 34:713–729
Moebus S, Hanisch J, Bramlage P et al (2008) Regional unterschiedliche Prävalenz des metabolischen Syndroms. Dtsch Ärztebl 105:207–213
Nocon M, Labenz J, Willich SN (2006) Lifestyle factors and symptoms of gastrooesophageal reflux – a population-based study. Aliment Pharmacol Ther 23:169–174
O’Neill S, O’Driscoll L (2015) Metabolic syndrome: a closer look at a growing epidemic and its associated pathologies. Obes Rev 16:1–12
Radmard AR, Merat S, Kooraki S et al (2015) Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences. Ann Hepatoloy 14:702–709
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1495–1607
Reis JP, Powell-Wiley T, Hankinson AL et al (2013) Duration of abdominal obesity beginning in young adulthood and incident diabetes through middle age. Diabetes Care 36:1241–1247
Reyes C, Leyland KM, Peat G et al (2016) Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol 68:1869–1875
Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666–678
Schipf S, Alte D, Völzke H et al (2010) Ergebnisse der Study of Health in Pomerania (SHIP). Diabetologia 5:161–168
Stamler J, Dyer AR, Shekelle RB (1993) Relationship of basal major risk factors in coronary and all-cause mortality, and to longeviti: findings from long-term follow-up Chicago cohorts. Cardiology 82:191–222
Subak LL, Richter HE, Hunskaar S (2009) Obesity and urinary incontinence: epidemiology and clinical research update. J Urol 182:S2–S7
Velho S, Paccoud F, Waeber C et al (2010) Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 64:1043–1051
Winter Y, Rohrmann S, Linseisen J et al (2010) Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 39:3145–3151
Wirth A (2007) Adipositas – eine Krankheit? Cardiovasc 7:28–34
Wirth A, Hauner H (Hrsg) (2008) Adipositas. Ätiologie, Folgekrankheiten, Diagnostik, Therapie, 3. Auf. Springer, Berlin
Wirth A, Hauner H (Hrsg) (2013) Adipositas. Ätiologie, Folgekrankheiten, Diagnostik, Therapie, 4. Auf. Springer, Berlin
Young T, Palta M, Dempsey J, Skatrud J, St Weber, Badr S (1993) The occurence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235
Zhang TT, Liu YL, Zhao JJ et al (2018) Obesity as a risk factor for low back pain: a meta-analysis. Clin Spine Surg 31:22–27 (Epub ahead of print)
Zheng H, Chen C (2015) Body mass index and risk of knee osteoarthritis: systematic review and meta-analysis of prospective studies. BMJ Open 5:e007568doi10.1136/bmjopen-2014-007568 2015
Zhou ZY, Chen HL, Liu F (2014) Body mass index and knee osteoarthritis risk: a dose-response meta-analysis. Obesity 22:2180–2185
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Wirth, A. (2019). Körperliche Komplikationen der Adipositas. In: de Zwaan, M., Herpertz, S., Zipfel, S. (eds) Psychosoziale Aspekte der Adipositas-Chirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57364-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-57364-8_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57363-1
Online ISBN: 978-3-662-57364-8
eBook Packages: Medicine (German Language)